10:49am Bayer Receives EU Approval for High-Dose Eylea in Another Indication DP
01-16 Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup DJ
01-16 Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation BU
01-16 Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation RE
01-16 Bayer AG - Company expects a decision on merits during court's 2026 session, which ends in June RE
01-16 Bayer AG - U.S. Supreme Court today announced that it will review Durnell Roundup case RE
01-16 Bayer : welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation PU
01-16 US Supreme Court to hear Bayer's bid to curb Roundup cases RE
01-16 U.S. Supreme Court agrees to hear Bayer's bid to limit lawsuits filed under state laws over its weedkiller Roundup RE
01-16 Bayer's Eylea Secures EU Approval for Retinal Vein Occlusion MT
01-16 MWB Research Upgrades Bayer to Buy, Boosts PT MT
01-16 Bayer Receives EU Approval for High-Dose Eylea in Another Indication DP
01-16 Bayer : Eylea™ 8 mg approved in the EU for third retinal indication PU
01-16 Bayer says Eylea 8 mg approved in the EU for third retinal indication RE
01-16 BAYER AG : UBS sticks Neutral ZD
01-16 Dax Expected to Open Lower – Inflation and Auto Sector in Focus RE
01-15 Bayer Upgraded to Buy as mwb Notes 'Improving Medium-term Risk-Reward' MT
01-15 European Midday Briefing : Shares Rise; Gold and Oil Fall on Easing U.S.-Iran Tensions DJ
01-14 German DAX Index Slips; Bayer, RWE Shares Surge MT
01-14 Frankfurt Stocks Close: DAX Ends Impressive Record-Breaking Streak DP
01-14 Orion Sees Long-Term Nubeqa Sales Surpassing 1 Billion Euros – Issues 2026 Forecast (Update) FW
01-14 Orion Estimates to Hit Annual Net Sales Target for Nubeqa by Decade-end MT
01-14 Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug DJ
01-14 Bayer Continues Recovery Rally – Sees Major Pharma Potential Ahead DP
01-14 Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle Zonebourse
No results for this search